Dexcom launches first over-the-counter continuous glucose monitor. Here's what it's like
Dexcom launched its first over-the-counter continuous glucose monitor called Stelo on Monday. Users can buy a one-month ...
Business Insider1 个月
Dexcom’s Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
Dexcom (DXCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on January 13. Analyst Mike Kratky from Leerink Partners maintained a Buy rating on the ...
pharmaphorum4 天
FDA clears first OTC glucose biosensor, from Dexcom
The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...
Kiplinger6 个月
Dexcom Stock Sinks on Sales Miss, Guidance Cut: What to Know
Dexcom (DXCM) stock is down over 40% in Friday's session after the continuous glucose monitoring technology company fell short of revenue estimates for its second quarter and slashed its full-year ...